162 related articles for article (PubMed ID: 38161202)
1. The risk of concurrent malignancies in patients with multiple endocrine neoplasia type 1: insights into clinical characteristics of those with multiple endocrine neoplasia type 1.
Zhao YX; Wang O; Song A; Wang LJ; Gong FY; Duan L; Yang HB; Pan H; Zhu HJ
J Endocrinol Invest; 2023 Dec; ():. PubMed ID: 38161202
[TBL] [Abstract][Full Text] [Related]
2. Multiple endocrine neoplasia type 1 and 2: from morphology to molecular pathology 1997.
Komminoth P
Verh Dtsch Ges Pathol; 1997; 81():125-38. PubMed ID: 9474863
[TBL] [Abstract][Full Text] [Related]
3. [Multiple endocrine neoplasia syndromes. Type 2].
Juodele L; Juozaityte E; Zindzius A; Pundzius J
Medicina (Kaunas); 2005; 41(4):281-94. PubMed ID: 15864001
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
5. Multiple endocrine neoplasia: the Chilean experience.
Diaz RE; Wohllk N
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):7-11. PubMed ID: 22584699
[TBL] [Abstract][Full Text] [Related]
6. Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing.
Chang CC; Chang YS; Huang HY; Yeh KT; Liu TC; Chang JG
Hum Pathol; 2018 Aug; 78():151-158. PubMed ID: 29753010
[TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1 combined with thyroid neoplasm: A case report and review of literatures.
Xu JL; Dong S; Sun LL; Zhu JX; Liu J
World J Clin Cases; 2022 Jan; 10(3):1032-1040. PubMed ID: 35127917
[TBL] [Abstract][Full Text] [Related]
9. A Possible New Multiple Endocrine Neoplasia Mutation in a Patient with a Prototypic Multiple Endocrine Neoplasia Presentation.
Buzzola R; Kurukulasuriya LR; Touza M; Litofsky NS; Brietzke S; Sowers JR
Cardiorenal Med; 2016 Feb; 6(2):129-34. PubMed ID: 26989398
[TBL] [Abstract][Full Text] [Related]
10. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.
Kim BY; Park MH; Woo HM; Jo HY; Kim JH; Choi HJ; Koo SK
BMC Med Genet; 2017 Oct; 18(1):106. PubMed ID: 28969599
[TBL] [Abstract][Full Text] [Related]
12. Multiple endocrine neoplasia type 1 associated with breast cancer: A case report and review of the literature.
Jeong YJ; Oh HK; Bong JG
Oncol Lett; 2014 Jul; 8(1):230-234. PubMed ID: 24959251
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature.
Deng J; Liao X; Cao H
Medicine (Baltimore); 2023 Jul; 102(29):e34350. PubMed ID: 37478229
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database.
Giusti F; Cianferotti L; Boaretto F; Cetani F; Cioppi F; Colao A; Davì MV; Faggiano A; Fanciulli G; Ferolla P; Ferone D; Fossi C; Giudici F; Gronchi G; Loli P; Mantero F; Marcocci C; Marini F; Masi L; Opocher G; Beck-Peccoz P; Persani L; Scillitani A; Sciortino G; Spada A; Tomassetti P; Tonelli F; Brandi ML
Endocrine; 2017 Nov; 58(2):349-359. PubMed ID: 28132167
[TBL] [Abstract][Full Text] [Related]
15. Second Primary Cancer Among Patients With Papillary Thyroid Carcinoma Following the Chernobyl Disaster.
Taha A; Taha-Mehlitz S; Nadyrov EA; Zinovkin D; Veyalkin I; Levin L; Pranjol MZI; Melling N; Honaker MD; Cattin PC; Schmid RA
JAMA Netw Open; 2023 Aug; 6(8):e2329559. PubMed ID: 37589974
[TBL] [Abstract][Full Text] [Related]
16. Papillary thyroid carcinoma and multiple endocrine neoplasia type 2.
Febrero B; Rodríguez JM; Ríos A; Portillo P; Parrilla P
J Endocrinol Invest; 2015 Nov; 38(11):1233-7. PubMed ID: 25903693
[TBL] [Abstract][Full Text] [Related]
17. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
Kazubskaia TP; Kozlova VM; Kondrat'eva TT; Pavlovskaia AI; Marakhonov AV; Baranova AV; Ivanova NI; Stepanova AA; Poliakov AV; Belev NF; Brzhezovskiĭ VZh
Arkh Patol; 2014; 76(5):3-12. PubMed ID: 25543402
[TBL] [Abstract][Full Text] [Related]
18. Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1).
Lairmore TC; Piersall LD; DeBenedetti MK; Dilley WG; Mutch MG; Whelan AJ; Zehnbauer B
Ann Surg; 2004 May; 239(5):637-45; discussion 645-7. PubMed ID: 15082967
[TBL] [Abstract][Full Text] [Related]
19. Expression of papillary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Decker RA
Surgery; 1993 Dec; 114(6):1059-63. PubMed ID: 7903002
[TBL] [Abstract][Full Text] [Related]
20. New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma.
Costa V; Esposito R; Ziviello C; Sepe R; Bim LV; Cacciola NA; Decaussin-Petrucci M; Pallante P; Fusco A; Ciccodicola A
Oncotarget; 2015 May; 6(13):11242-51. PubMed ID: 25803323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
